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We report on the role of vpu in the pathogenesis of a molecularly cloned simian-human immunodeficiency virus
(SHIVKU-1bMC33), in which the tat, rev, vpu, env, and nef genes derived from the uncloned SHIVKU-1b virus were inserted into the
genetic background of parental nonpathogenic SHIV-4. A mutant was constructed (DvpuSHIVKU-1bMC33) in which 42 of 82 amino
acids of Vpu were deleted. Phase partitioning studies revealed that the truncated Vpu was not an integral membrane protein,
and pulse-chase culture studies revealed that cells inoculated with DvpuSHIVKU-1bMC33 released viral p27 into the culture
medium with slightly reduced kinetics compared with cultures inoculated with SHIVKU-1bMC33. Inoculation of DvpuSHIVKU-1bMC33
into two pig-tailed macaques resulted in a severe decline of CD41 T cells and neurological disease in one macaque and a
more moderate decline of CD41 T cells in the other macaque. These results indicate that a membrane-bound Vpu is not
required for the CD41 T cell loss and neurological disease in SHIV-inoculated pig-tailed macaques. Furthermore, because the
amino acid substitutions in the Tat and Rev were identical to those previously reported for the nonpathogenic SHIVPPc, our
results indicate that amino acid substitutions in the Env and/or Nef were responsible for the observed CD41 T cell loss and
neurological disease after inoculation with this molecular clone. © 2000 Academic Press
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Simian-human immunodeficiency viruses (SHIVs) con-
taining regions of the HIV-1 genome in an SIVmac genetic
ackground represent a model system for analyzing the
ole of HIV-1-specific gene products (i.e., Vpu) in the
athogenesis of this virus. In previous studies, we dem-
nstrated that nonpathogenic SHIV-4 containing the tat,
ev, vpu, and env genes from the HXBc2 strain of HIV-1 in
genetic background of SIVmac239 could be serially pas-
saged in pig-tailed macaques to select a pathogenic
variant (SHIVKU-1). The disease in pig-tailed macaques is
characterized by an early phase of transiently high vire-
mia, p27 antigenemia, and massive loss of circulating
CD41 T cells within the first 2–4 weeks that is sustained
throughout the course of their infection (Joag et al., 1996).
The majority of SHIVKU-1-inoculated pig-tailed macaques
die of their infection within 8 months after inoculation
(Joag et al., 1997).
HIV-1 and SIVCPZ are the only lentiviruses that encode
Vpu protein. Vpu is an 82-amino-acid integral mem-
rane protein, with the amino terminus composed of a
ydrophobic region that spans the membrane and an
ydrophilic carboxyl terminus that extends into the cyto-1 To whom reprint requests should be addressed. Fax: (913) 588-
295. E-mail: estephen@kumc.edu.
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112lasm (Maldarelli et al., 1993). Within the cytoplasmic tail
re two predicted a-helical domains separated by a
egion containing two phosphorylation sites (Schubert et
l., 1994). Previous reports have provided data that Vpu
ncreases virus particle release from the plasma mem-
rane, decreases the amount of CD4 surface expression,
egulates intracellular transport of viral gp160, and de-
reases the cytopathic effects of the virus by diminishing
yncytia formation (Klimkait et al., 1990; Willey et al.,
992; Yao et al., 1993; Vincent et al., 1995; Schubert et al.,
995; Shubert et al., 1996; Paul and Jabbar, 1997; Paul et
l., 1998). However, these functional studies have been
imited to cell culture systems, and the role of Vpu in the
athogenesis of HIV-1 in humans is unknown.
In a recent study, we analyzed the molecular changes
hat were acquired during the derivation of a pathogenic
HIV from nonpathogenic SHIV-4 (McCormick-Davis et
l., 1998). Sequence analysis of integrated viral variants
solated throughout the course of infection from ma-
aques PPc and PQc, the first animals in the serial bone
arrow passages to develop severe CD41 T cell loss
and AIDS, revealed an association between the rever-
sion of the vpu gene to encode a protein and increased
amino acid substitutions in the Env and Nef proteins, as
well as the second phase of CD41 T cell loss. These
results suggested that either Vpu was required for the
pathogenicity of the virus or Vpu may have conferred a
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113MOLECULAR DETERMINANTS FOR CD41 T CELL LOSSreplicative advantage, resulting in the accumulation of
mutations in the Env and/or Nef that were ultimately
responsible for the observed CD41 T cell loss in pig-
ailed macaques. Studies have shown that the Vpu, Env,
nd Nef proteins are important in the down-regulation of
D4 from the surface of infected cells (Piguet et al.,
999). To analyze the individual contribution of the vpu
ene product in the CD41 T cell loss caused by patho-
genic SHIV, we constructed a molecular clone containing
the consensus tat, rev, vpu, env, and nef sequences from
uncloned pathogenic SHIVKU-1b in the genetic background
of nonpathogenic SHIV-4. We used this molecular clone
(SHIVKU-1bMC33) to determine whether a membrane-bound
pu has a role in the CD41 T cell loss caused by SHIV.
Our results indicate that a membrane-bound Vpu is not
required for CD41 T cell loss and neuro-AIDS in pig-
ailed macaques inoculated with SHIVKU1-bMC33.
RESULTS
olecular characterization of SHIVKU-1bMC33
Figure 1 is a schematic representation of the
SHIVKU-1bMC33 genome and the origin of the tat, rev, vpu,
env, and nef genes in the SHIV-4 genetic background.
The predicted amino acid substitutions in the Tat, Rev,
and Vpu were identical to those previously reported for
the nonpathogenic SHIVPPc molecular clone (Stephens et
al., 1998). The amino acid substitutions in the Env were
identical to those previously reported for the molecular
FIG. 1. Schematic diagram of the construction of the 39 half of the SH
he restriction endonuclease sites used to construct SHIVKU-1bMC33 are s
FIG. 2. Comparison of the predicted sequence of the unmodified
DvpuSHIVKU-1bMC33. Those residues with (*) above the sequence represen
(c) above the sequence represent amino acids in the two predicted cytoplas
been shown to be phosphorylated. The (:) in the truncated Vpu sequence repclone SHIVKU-1bMC17 (Narayan et al., 1999). We report here
on the changes in the Nef protein. Sequence analysis of
nef revealed a total of six amino acid substitutions
(P12T, D37N, N72D, I144M, T170A, and E191K) in the
SHIVKU-1bMC33 Nef in comparison with parental SHIV-4.
Analysis of DvpuSHIVKU-1bMC33
To determine the role of the vpu gene product in the
SHIV-induced CD41 T cell loss in pig-tailed macaques,
we constructed a deletion in the vpu gene of this virus
(Fig. 2). This mutant resulted in the deletion of 42 of the
82 amino acids from Vpu, which included three regions
previously shown to be essential for the Vpu function.
First, part of the transmembrane domain was deleted,
and analysis of the protein sequence predicts that it is no
longer an integral membrane protein. A membrane-
bound Vpu has been implicated in efficient viral particle
release (Tiganos et al., 1998; Paul et al., 1998). Second,
the first a-helical region of the cytoplasmic domain was
eleted, and this domain was previously shown to inter-
ct with CD4 (Tiganos et al., 1997). Third, one of two
erine residues previously shown to be phosphorylated
nd necessary for CD4 down-regulation was deleted
Schubert and Strebel, 1994). To determine whether this
runcated protein was expressed in cells, C8166 cells
ere inoculated with either SHIVKU-1bMC33 or Dvpu-
SHIVKU-1bMC33, and immune precipitation assays were per-
formed. As shown in Fig. 3, the intact Vpu with a molec-
C33 genome. The origin of the specific regions of the viral genome and
in SHIV-4, SHIVKU-1bMC33, and the truncated predicted Vpu protein in
amino acids in the predicted membrane spanning domain, those withVpu
t thosemic a-helical domains, and the two serine residues in bold type have
resents the deleted amino acids.
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114 MCCORMICK-DAVIS ET AL.ular weight of approximately 16,000 was immunoprecipi-
tated from C8166 cells inoculated with SHIVKU-1bMC33. The
truncated Vpu expressed in DvpuSHIVKU-1bMC33-inoculated
cells should have a molecular weight of approximately
4300. As shown in Fig. 3A, a protein with this molecular
weight was immunoprecipitated from DvpuSHIVKU-1bMC33-
FIG. 3. Immune precipitation analysis of the truncated Vpu in
vpuSHIVKU-1bMC33-infected cells. (A) 10
4 TCID50 of DvpuSHIVKU-1bMC33 or
SHIVKU-1bMC33 was used to inoculate C8166 cells. At 5 days postinocu-
ation, cells were starved for methionine and cysteine and radiolabeled
ith 1 mCi of 35S-methionine and cysteine for 18 h. Cell lysates were
prepared and Vpu proteins were immunoprecipitated using a rabbit
anti-Vpu serum and protein A–Sepharose as described under Materials
and Methods. Immune precipitates were washed three times in RIPA
buffer, and samples were denatured by boiling in SDS–PAGE sample
reducing buffer. Proteins were separated by SDS–PAGE (12.5% gel) and
visualized using standard autoradiographic techniques. Lane 1, pro-
teins immune precipitated from uninfected C8166 cells. Lane 2, pro-
teins immune precipitated from C8166 cells inoculated with
DvpuSHIVKU-1bMC33. Lane 3, proteins immune precipitated from C8166
cells inoculated SHIVKU-1bMC33. (B) 10
4 TCID50 of DvpuSHIVKU-1bMC33 or
HIVKU-1bMC33 was used to inoculate C8166 cells. At 5 days postinocu-
ation, cells were starved for methionine and cysteine and radiolabeled
ith 1 mCi of 35S-methionine and cysteine for 18 h. Lysates were
repared and partitioned in Triton X-114 as described in Materials and
ethods. Lane 1, proteins immune precipitated from uninfected C8166
ells; lane 2, Vpu proteins immune precipitated from supernatant phase
f SHIVKU-1bMC33-infected cells after Triton X-114 partitioning; lane 3, Vpu
roteins immune precipitated from pellet phase of SHIVKU-1bMC33-infected
ells after Triton X-114 partitioning; lane 4, Vpu proteins immune pre-
ipitated from uninfected C8166 cells; lane 5, Vpu proteins immune
recipitated from pellet phase of DvpuSHIVKU-1bMC33-infected cells of a
Triton X-114 partitioning; and lane 6, Vpu proteins immune precipitated
from supernatant phase of DvpuSHIVKU-1bMC33-infected cells after Triton
-114 partitioning.noculated cultures using the a-Vpu serum, confirming
he deletion. We examined the truncated Vpu protein
c
gxpressed from DvpuSHIVKU-1bMC33 to determine whether it
as partitioned into the detergent phase after Triton
-114 extraction (Bordier et al., 1981). As shown in Fig.
B, the intact Vpu was found in both the supernatant and
etergent phases after partitioning of SHIVKU-1bMC33-in-
ected cells with Triton X-114, with the majority of it in the
etergent phase. In contrast, the truncated Vpu was
xclusively found in the supernatant phase. Isolation of
embrane and cytoplasmic fractions from Dvpu-
HIVKU-1bMC33-infected C8166 cells confirmed that the trun-
ated Vpu was in the cytoplasmic fraction. These results
ndicate that unlike the intact Vpu, the truncated Vpu did
ot have properties of an integral membrane protein.
ecause previous studies have shown that Vpu expres-
ion results in more efficient release of virus particles
rom infected cells, we used pulse-chase analysis to
etermine whether truncation of the Vpu would result in
ecreased release of viral proteins from infected cells.
he results of experiments shown in Figs. 4A and 4B
emonstrate that the viral p27 was released from
vpuSHIVKU-1bMC33-infected C8166 cells with slightly de-
layed kinetics compared with SHIVKU-1bMC33-inoculated
cultures.
DvpuSHIVKU-1bMC33 causes CD4
1 T cell loss and
euro-AIDS in pig-tailed macaques
To assess the role of Vpu in the CD41 T cell loss in
ig-tailed macaques inoculated with SHIVKU-1bMC33, two
pig-tailed macaques (50 O and 50 Y) were inoculated
with DvpuSHIVKU-1bMC33. Virus loads and CD4
1 T cell
counts were then monitored for 9 months (Fig. 5A). Sim-
ilar to previous studies, infectious centers assays (ICAs)
detected the highest number of cells producing virus at
2 weeks postinoculation [10,000 cells/106 peripheral
lood mononuclear cells (PBMCs)]. After inoculation with
vpuSHIVKU-1bMC33, the circulating CD4
1 T cell numbers in
acaque 50 O dropped from 1024 at week 0 to 59
ells/ml by week 4. From 4 weeks to 35 weeks, CD41 T
cell numbers remained low, ranging from 65 to 126 cells/
ml. This macaque became blind and developed tremors
and was euthanized at 35 weeks postinoculation. Histo-
logical examination of the spleen and lymph node re-
vealed severe lymphoid depletion that is characteristic of
pathogenic SHIV infections (Joag et al., 1996, 1997). Anal-
ysis of the PBMCs and cells from the spleen and lymph
node at necropsy revealed cells producing infectious
cytopathic virus that ranged from 10,000 cells/106 lymph
node cells to 100/106 spleen cells and PBMCs. Virus was
recovered from the plasma ($103 TCID50) and from lung
homogenates (102 TCID50), although no histological le-
sions were evident in the lungs. Virus was also recov-
ered from the cerebrospinal fluid (CSF) ($103 TCID50) as
ell as from homogenates prepared from the parietal
ortex and basal ganglia. Examination of tissues for viral
ag sequences revealed that all visceral organs were
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115MOLECULAR DETERMINANTS FOR CD41 T CELL LOSSpositive (Fig. 6A). Examination of the same tissues re-
vealed that the PBMCs and all visceral organs with the
exception of the liver were positive for 2-long terminal
repeat (LTR) circular forms of the viral genome, indicating
that active viral replication was occurring in most vis-
ceral organs (Fig. 6B). Histological examination of the
central nervous system (CNS) revealed lesions consis-
tent with lentiviral encephalitis (formation of microglial
nodules and perivascular cuffing with mononuclear
cells) in all 14 regions of the brain examined (Fig. 7). In
macaque 50 O, extensive perivascular cuffing was ap-
parent in the lateral geniculate nucleus (Fig. 7B), pons
(Fig. 7L), and cortical areas, including the motor cortex
(Fig. 7K). By comparison, the lateral geniculate nucleus
of macaque 50 Y appeared normal (Figs. 7C and 7D).
This pathology in the lateral geniculate nucleus provides
an explanation of the blindness in this animal, because
the retina itself appeared normal (data not shown). Ma-
FIG. 4. Pulse chase analysis of gp120 and p27 in C8166 cultures ino
inoculated with SHIVKU-1bMC33 or DvpuSHIVKU-1bMC33 as described in Mate
ethionine and cysteine and then pulse labeled with 1 mCi of 35S-methio
and washed once with medium containing 1003 cold methionine an
periods of time (0, 1, 2, 4, and 6 h). The culture medium was collected, a
were immunoprecipitated using a pooled serum from four macaques t
he cell lysates and culture medium from SHIVKU-1bMC33-inoculated C8166
ell lysates and culture medium from DvpuSHIVKU-1bMC33-inoculated C81
ere radiolabeled and chased for 6 h served as a negative control (la
7.5% gel) and visualized by standard fluorographic techniques.caque 50 O also showed astrocyte activation throughout
the cortex, as assessed by GFAP staining (see Fig. 7E foran example of parietal cortex), which was not present in
macaque 50 Y (Fig. 7F). Astrocyte activation in the sub-
cortical white matter was also more apparent in ma-
caque 50 O (Fig. 7G) than in macaque 50 Y (Fig. 7H). In
addition, macaque 50 O showed extensive microglial
activation as assessed by expression of MHC-II (Fig. 7I),
compared with macaque 50 Y, where the level of MHC-II
expression in subcortical white matter was comparable
to age-matched uninoculated macaques (Fig. 7J). All re-
gions of the CNS were positive for SIV gag sequences,
and examination of the CNS tissues revealed that 4 of 14
regions were also positive for 2-LTR circular forms, indi-
cating that active spread of the virus infection was oc-
curring in the basal ganglia, midbrain, pons, and medulla
regions of the CNS at the time of necropsy (Fig. 8B).
Interestingly, the regions in which 2-LTR circles were
detected also corresponded with the regions displaying
the most severe lesions. Consistent with the lesions
with SHIVKU-1bMC33 and DvpuSHIVKU-1bMC33. Cultures of C8166 cells were
Methods. At 4 days postinnoculation, infected cells were starved for
nd cysteine for 1 h. The medium containing the radiolabel was removed
ine, and the radiolabel was chased in the same medium for varying
lysates were prepared as described in the text. SHIV-specific proteins
been infected with SHIVKU-1 for 6 months. SHIV-specific proteins from
es are shown in A and B, respectively. SHIV-specific proteins from the
ures are shown in C and D, respectively. Uninfected C8166 cells that
All samples were analyzed under reducing conditions by SDS–PAGEculated
rial and
nine a
d cyste
nd cell
hat had
cultur
66 cult
nes C).found in the CNS was the number of genomic copies of
virus found in the brain of this macaque using the PCR/
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116 MCCORMICK-DAVIS ET AL.ICA technique. As shown in Fig. 9, the number of
genomic copies in the brain (parietal cortex and pons)
and lymph node tissue ranged from 104 to 105 copies/106
genomic equivalents, similar to what we previously re-
ported for macaques with SIVmac encephalitis (Stephens
et al., 1998a). The presence of high levels of virus in the
CNS was confirmed by the finding of high concentrations
of p27 antigen in cell-free homogenates prepared from
different regions of the brain (Fig. 10). To rule out that the
encephalitis was caused by two common opportunistic
pathogens that can be reactivated after inoculation with
pathogenic SHIV, we examined the different regions of
the CNS from this macaque for SV-40 and CMV viral
sequences (Raghavan et al., 1997). Using nested DNA
PCR, we were unable to detect SV-40 or rhesus CMV
sequences in the DNA isolated from 14 regions of the
CNS of this macaque (Figs. 10C and 10D).
Macaque 50 Y had a more gradual decline in its
CD41 T cell numbers, which dropped from 796 cells/ml
at week 0 to 251 cells/ml at week 4 (Fig. 5B). From 1 to
9 months, the CD41 T cell numbers in the PBMCs
varied from 246 to 466 cells/ml. ICA detected the
ighest number of cells producing virus at 2 weeks
ostinoculation (1000 cells/106 PBMCs for 50 Y). Sim-
ilarly, cytopathic virus was recovered from the plasma
only at 2 weeks postinoculation. This macaque was
sacrificed at 39 weeks postinoculation to examine the
visceral organs and CNS for virus content. Histological
FIG. 5. The levels of CD41 T cells (F) and numbers of cells producing
infectious virus (f) in macaques 50 O (A) and 50 Y (B) after inoculation
with DvpuSHIVKU-1bMC33.examination of the lymph node, spleen, and thymus
showed moderate depletion of germinal centers, butthere were no lesions in the brain or spinal cord.
Examination of the PBMCs, spleen, and lymph node
cells by ICA revealed that only the lymph node had
cells producing infectious, cytopathic virus (10,000/106
lymph node cells). In addition, no cytopathic virus was
recovered from the CSF, plasma, or lung homogenates
from macaque 50 Y. However, inoculation of CSF and
plasma from this macaque into C8166 cultures re-
sulted in the establishment of persistently infected
cultures without apparent cytopathology. Examination
of the PBMCs and visceral organs revealed that all
were positive for gag sequences by nested DNA PCR
Fig. 11). With the exception of the liver, these same
NA samples were positive for 2-LTR circular forms of
he viral genome, indicating that ongoing virus repli-
ation was occurring in these organs, despite the
nability to recover infectious cells using infectious
enters assays. Examination of DNA isolated from 14
egions of the CNS revealed that 8 of 14 regions were
ositive for gag sequences and only 1 region was
ositive (i.e., basal ganglia) for 2-LTR circular forms.
e compared the number of viral copies in brain and
ymph node tissue. Similar to macaque 50 O, there
ere 105 viral genome copies/106 genome equivalents
FIG. 6. PCR analysis of visceral organ tissue DNA preparations from
macaques 50 O and 50 Y for viral gag and 2-LTR sequences. DNA was
extracted from various organs and used in nested PCR using the
appropriate oligonucleotide primers specific for SHIV and SIV as de-
scribed in the text. Ten ml of the reaction products were run in a 1.5%
agarose gel and stained with ethidium bromide. (A) Agarose gel show-
ing the presence of gag sequences in the visceral organs from ma-
caques 50 O and 50 Y. Lanes 1–5, macaque 50 O; lanes 8–12, macaque
50 Y; lanes 6 and 13, negative controls; lanes 7 and 14, positive
controls; lanes 1 and 8, mesenteric lymph node; lanes 2 and 9, liver;
lanes 3 and 10, lung; lanes 4 and 11, spleen; and lanes 5 and 12,
thymus. (B) Agarose gel showing the presence of 2-LTR sequences in
the visceral organs from macaques 50 O and 50 Y. Lanes 1–5, macaque
50 O; lanes 8–10, macaque 50 Y; lane 11, positive control; lane 12,
negative controls; lanes 1 and 6, mesenteric lymph node; lanes 2 and
7, liver; lanes 3 and 8, lung; lanes 4 and 9, spleen; and lanes 5 and 10,
thymus.
a
g
: A–D,
117MOLECULAR DETERMINANTS FOR CD41 T CELL LOSSin lymph node tissue. However, the two regions of the
brain analyzed, the parietal cortex and the pons, had
very low levels of virus (101 to 102 viral copies/106
FIG. 7. Histological examination reveals the extensive pathology in the
Materials and Methods and then stained with thionin (A–D), for GFAP (E
geniculate nucleus in 50 O showing extensive perivascular cuffing and nu
in layers 1 and 2 of the lateral geniculate nucleus of 50 O. (C) Lateral genic
(D) Higher-magnification view of the lateral geniculate nucleus in 50 Y co
of 50 O revealing obvious astrocyte activation. (F) GFAP in parietal cortex o
matter of 50 O showing astrocyte activation. (H) GFAP in white matter of 50
extensive microglial activation. (J) MHC-II in subcortical white matter of 50
Sheffield and Berman, 1998). (K) Hematoxylin and eosin stain of a lesion
stain of a lesion in pons of 50 O showing perivascular cuffing. Scale barsgenome equivalents) compared with macaque 50 O
and is similar to what we reported for macaques
p
sinfected with non-neurovirulent SIVmac239 (Stephens et
l., 1998a). Examination of DNA isolated from 14 re-
ions of the CNS revealed 0 of 14 and 5 of 14 regions
of macaque 50 O. Histological sections were prepared as described in
r MHC-II (I and J), or with hematoxylin and eosin (K and L). (A) Lateral
microglia nodules. (B) Higher-magnification view of perivascular infiltrate
ucleus of 50 Y showing no obvious lesions were present in this macaque.
no microglia nodules or perivascular cuffing. (E) GFAP in parietal cortex
howing normal staining of pial glial limitans. (G) GFAP in subcortical white
ing normal fibrous astrocytes. (I) MHC-II in parietal cortex of 50 O showing
ing light staining of microglia comparable to age-matched controls (see
r cortex of 50 O showing perivascular cuffing. (L) Hematoxylin and eosin
500 mm; E–L, 250 mm.brain
–H), fo
merous
ulate n
ntaining
f 50 Y s
Y show
Y show
in motoositive for rhesus CMV and SV-40 sequences, re-
pectively (Fig. 11).
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118 MCCORMICK-DAVIS ET AL.The truncated vpu gene was stable in both infected
macaques
We amplified the vpu sequences from DNA isolated
from the PBMCs, lymph node, and spleen of both ma-
caques and from three regions of the brain (pons, basal
ganglia, and parietal cortex) from macaque 50 O at nec-
ropsy to examine the integrity of the vpu deletion. In all
cases, the amplified product was consistent with the size
of the deletion in DvpuSHIVKU-1bMC33 (data not shown).
FIG. 8. PCR analysis of macaque 50 O CNS tissue DNA preparations
for SHIV, CMV, and SV-40 sequences. DNA was extracted from 14
regions of the CNS and used in nested PCR with the appropriate
oligonucleotide primers specific for SHIV, SV-40, and CMV as de-
scribed in the text. Ten ml of the reaction products were run in a 1.5%
agarose gel and stained with ethidium bromide. (A) Agarose gel show-
ing the presence of gag sequences in 14 regions of the CNS. (B)
garose gel showing the absence of SV-40 sequences in the 14
egions of the CNS. (C) Agarose gel showing the absence of CMV
equences in 14 regions of the CNS. (D) Agarose gel showing the
resence or absence of SHIV 2-LTR sequences in 14 regions of the
NS. Lane 1, frontal cortex; lane 2, motor cortex; lane 3, parietal cortex;
ane 4, occipital cortex; lane 5, temporal cortex; lane 6, corpus callo-
um; lane 7, basal ganglia; lane 8, midbrain; lane 9, pons; lane 10,
edulla; lane 11, cerebellum; lane 12, cervical spinal cord; lane 13,
horacic spinal cord; lane 14; lumbar spinal cord; lane 15, negative
ontrol; and lane 16, positive control. The negative control was DNA
solated from the PBMCs of uninfected macaques. The positive control
or panel A was DNA from the lymph node tissue from macaque PPc,
hose gag region was previously amplified, cloned, and sequenced.
he positive control for panel B was DNA from the frontal cortex of
acaque 16B, which we previously reported as positive for SV-40
equences (Raghavan et al., 1997). The positive control for panel C was
NA from the frontal cortex of macaque 23A, which we previously
eported as positive for rhesus CMV sequences (Raghavan et al., 1997).
he positive control for panel D was 1 ng of DNA containing the 2-LTR
equences isolated from C8166 cells 36 h after inoculation with
HIVKU-1bMC33.equence analysis of the amplified vpu genes from three
issues of macaque 50 Y and six tissues of macaque 50indicated that only the truncated vpu gene was present
n these tissues and that no additional changes had
ccurred in this gene. Thus, these results indicate that
runcated vpu was stable throughout the course of the
nfection.
DISCUSSION
In this study, we generated a virus in which Vpu was
runcated in the context of a pathogenic SHIV back-
round. This molecular clone, DvpuSHIVKU-1bMC33, has
ore than 50% of the coding region for Vpu deleted (42
f 82 amino acids). Included in the deleted region was
FIG. 9. Viral copy number in the lymph node (LN), parietal cortex (PC),
and pons (PN) tissues in macaques 50 O and 50 Y. Total cellular DNA
was extracted from the tissues and used to quantify the number of
viral copies/106 genome equivalents as described in Materials and
Methods.
FIG. 10. CNS tissues from macaque 50 O but not 50 Y have high
levels of p27 antigen. Cell-free homogenates were prepared from the
three regions of the CNS [parietal cortex (PC), basal ganglia (BG), and
cerebellum (CB)] and used in antigen capture assays.
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119MOLECULAR DETERMINANTS FOR CD41 T CELL LOSSthe first a-helix and the phosphoserine residue at posi-
tion 52, which together with the phosphoserine at amino
acid position 56 have been shown in an in vitro setting to
be important for the function of Vpu. Analysis of this
truncated protein predicts that it should not be stably
incorporated into the membrane, and unlike the intact
Vpu protein, we showed that the truncated Vpu mutant
protein did not partition into the detergent phase of a
Triton X-114 extraction (Fig. 3B). This is consistent with
this protein not being incorporated into the membrane of
the rough endoplasmic reticulum. Analyses of mem-
brane and cytoplasmic fractions isolated from
DvpuSHIVKU-1bMC33-infected cells confirm these results
(data not shown). In addition, the pulse-chase analysis
FIG. 11. PCR analysis of macaque 50 Y tissue DNA preparations for
HIV, SV-40, and CMV sequences. DNA was extracted from 14 regions
f the CNS and used in nested PCR with the appropriate oligonucleo-
ide primers specific for SHIV, SV-40, and CMV as described in the text.
en ml of the reaction products were run in a 1.5% agarose gel and
tained with ethidium bromide. (A) Agarose gel showing the presence
f gag sequences in 14 regions of the CNS. (B) Agarose gel showing
he presence of SV-40 sequences in 5 of 14 regions of the CNS. (C)
garose gel showing the absence of CMV sequences in the 14 regions
f the CNS. (D) Agarose gel showing the presence or absence of 2-LTR
equences in 14 regions of the CNS. Lane 1, frontal cortex; lane 2,
otor cortex; lane 3, parietal cortex; lane 4, occipital cortex; lane 5,
emporal cortex; lane 6, corpus callosum; lane 7, basal ganglia; lane 8,
idbrain; lane 9, pons; lane 10, medulla; lane 11, cerebellum; lane 12,
ervical spinal cord; lane 13, thoracic spinal cord; lane 14, lumbar
pinal cord; lane 15, negative control; and lane 16. positive control. The
egative and positive controls were the same as those described in the
egend to Fig. 8.indicated that p27 protein was released from
DvpuSHIVKU-1bMC33-inoculated C8166 cultures at a slightly
r
ceduced rate from that seen in cultures inoculated with
arental SHIVKU-1bMC33 (Fig. 4), which is similar to studies
n HIV-1 lacking Vpu (Terwilliger et al., 1989; Yao et al.,
993; Iwatani et al., 1997). Further, recent studies with an
HIV lacking all of the vpu sequences before the env
howed a kinetics of p27 release from infected C8166
ells similar to that of the truncated mutant (C. McCor-
ick-Davis, unpublished data). Taken together, these
esults indicate that this truncated Vpu expressed from
vpuSHIVKU-1bMC33 is not membrane bound and exhibits a
phenotype similar to HIV-1 lacking a functional Vpu.
Two pig-tailed macaques, 50 O and 50 Y, were intra-
venously inoculated with Dvpu SHIVKU-1bMC33 to assess the
pathogenicity of this virus. One animal (50 O) developed
a severe decline in CD41 T cells within 4 weeks, and
ells producing infectious virus could be recovered
hroughout the course of infection. At the time of nec-
opsy, this macaque displayed signs of neurological dis-
ase that included blindness and tremors. Histological
xamination of the visceral organs revealed severe lym-
hoid depletion in the spleen and lymph nodes charac-
eristic of an infection with pathogenic SHIV (Joag et al.,
996, 1997). Cells producing infectious virus were readily
etected in the PBMCs, spleen, and lymph nodes. In
ddition, virus was recovered from cell-free homoge-
ates from the lung and brain as well as from plasma.
acaque 50 O also developed a severe SHIV-induced
ncephalitis. We base this observation on the presence
f encephalitic lesions in the brain and spinal cord
perivascular cuffing with mononuclear cells and micro-
lial nodules) that are typical for macaques with SHIV-
nd SIV-induced encephalitis (Raghavan et al., 1997,
999), high levels of virus in the brain, and increased
taining for GFAP and MHC-II, markers associated with
strocyte and microglial activation (Berman et al., 1998,
999). The microglial and astrocyte activation in ma-
aque 50 O was similar to what was reported for ma-
aques inoculated with neurovirulent SIVmac R71/17E and
in brains of humans with neuro-AIDS. In addition, we
were able to recover virus from the CNS and to detect the
presence of 2-LTR circles in several regions of the brain.
Several studies have shown that the presence of viral
genomes containing LTR circles are a sensitive indicator
of ongoing virus replication (Pauza et al., 1995; Teo et al.,
1997; Zazzi et al., 1997). The other macaque (50 Y) de-
eloped a more gradual drop in CD41 T cells that never
ecovered to the level seen before inoculation. Coculture
f PBMC with C8166 cells revealed cells producing in-
ectious virus only for the first 8 weeks from macaque 50
. At necropsy, cells producing infectious virus were
ecovered from the lymph node but not the spleen or
BMCs. However, analysis of these same samples for
-LTR circles by nested DNA PCR revealed that all were
ositive except for the liver, indicating that ongoing viruseplication was occurring. In addition, cytopathic virus
ould not be isolated from the lung homogenates or
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120 MCCORMICK-DAVIS ET AL.plasma when cultured with C8166 cells. However, pas-
sage of filtered culture supernatants into fresh C8166
cultures were routinely positive for virus by PCR despite
the lack of cytopathology, suggesting the presence of a
noncytopathic variant. The results presented here repre-
sent the first in vivo demonstration that a full-length vpu
ene product is not required for the severe CD41 T cell
loss after inoculation with a molecular clone of SHIV.
Whether the lack of a full-length, membrane-bound Vpu
is less pathogenic in larger groups of macaques and/or
whether macaque 50 O selected for mutations that com-
pensated for the lack of a full- length Vpu will be the
subject of future studies. Our results also indicate that a
functional Vpu is not required for neuropathogenesis in
the SHIV/macaque model system. In a previous study, it
was suggested that pig-tailed macaques were resistant
to SHIV-induced neuro-AIDS (Raghavan et al., 1997). The
results in this study indicate that neuro-AIDS can de-
velop in pig-tailed macaques after inoculation with this
molecularly cloned isolate of SHIV. Because the amino
acid substitutions that led to the derivation of a patho-
genic variant reside within the Tat, Rev, Vpu, and Env
and/or Nef proteins and because the amino acid substi-
tutions found in the first exon of Tat and Rev proteins of
SHIVKU-1bMC33 were identical to those found in a nonpatho-
genic molecular clone SHIVPPc, these results indicate that
the amino acid substitutions in the Env and/or Nef were
responsible for the CD41 T cell loss caused by
DvpuSHIVKU-1bMC33 (Stephens et al., 1998b; McCormick-
Davis et al., 1998; Narayan et al., 1999).
The in vivo experiments reported here with
DvpuSHIVKU-1bMC33 correlate well with studies that demon-
strated the envelope glycoproteins of an HIV-2 strain
(ROD10) could augment virus release of HIV-1, HIV-2, SIV,
as well as chimeric constructs, indicating that the HIV-2
Env could compensate for this function of Vpu (Bour et
al., 1996, Bour and Strebel, 1996). A recent report on a
naturally occurring point mutation within the initiation
codon of vpu demonstrated that enhanced envelope gly-
coprotein production could compensate for the function
of Vpu in virion release (Schubert et al., 1999). Further-
more, a molecularly cloned virus containing 12 amino
acid changes found in the SHIVKU-1 envelope glycopro-
eins had an increased ability to replicate in rhesus
BMCs that was not due to altered coreceptor use,
uggesting the affinity by which this Env binds to its
oreceptor is likely enhanced. Inoculation of this molec-
lar clone, containing the amino acid substitutions of the
HIVKU-1 Env in the context of a nonpathogenic back-
ground, into rhesus macaques resulted in a severe drop
in CD41 T cells (Cayabyab et al., 1999). Given these
results and those reported here, it is possible that amino
acid substitutions in the envelope glycoproteins may
have compensated for the lack of a functional Vpu protein.The results from this study also has important impli-
cations with regard to vaccine development. Earlier stud- Sies indicated that SIVmac239 variants in which the nef
gene was deleted were not pathogenic for adult ma-
caques and protected macaques from challenge with
virulent SIVmac239 (Daniel et al., 1992; Wyand et al., 1996).
ubsequent studies, however, have shown that a virus
ontaining a deleted nef, vpr, and vpx was pathogenic for
ewborn macaques and adult macaques (Baba et al.,
995, 1998). More recently, a study demonstrated the use
f vpu-deleted SHIV as the basis of an live, attenuated
accine (Joag et al., 1998). The results presented here as
ell as studies describing another nonpathogenic vari-
nt of SHIV-4 (Stephens et al., 1998) indicate that the
ifference between nonpathogenic and pathogenic vari-
nts of the same SHIV may be as little as a few amino
cid substitutions, suggesting that additional work must
e done on the use of gene-deleted live attenuated
entiviruses before they can be considered as viable
accine candidates.
MATERIALS AND METHODS
ells, plasmids, and cells
C8166 cell line was used as the indicator cells to
easure infectivity and cytopathicity of the viruses used
n this study. C8166 cells were maintained in RPMI 1640,
upplemented with 10 mM HEPES buffer, pH 7.3, 2 mM
lutamine, 50 mg/ml gentamicin, and 10% fetal bovine
serum (R10FBS). The derivation of SHIVKU-1b from ma-
caque PNb has been previously described (Narayan et
al., 1999). The p39SHIV-4 and p59SHIV-4 plasmids were
obtained from Dr. Joseph Sodroski at Harvard Univer-
sity (Li et al., 1992). The construction of plasmid
p39SHIVKU-1bMC17, which contains the consensus se-
uence of env and the first 205 nucleotides of nef from
he SHIVKU-1b virus stock, has been described previously
Narayan et al., 1999).
ntibodies
A positive control serum for immune precipitation con-
isted of pooled serum samples from four macaques that
ad been infected with SHIVKU-1 for 6 months, and a
egative control serum was derived from an uninfected
acaque. The Vpu antiserum was obtained through the
IDS Research and Reference Reagent Program, Divi-
ion of AIDS, NIAID, NIH, from Drs. Frank Maldarelli and
laus Strebel.
onstruction of SHIVKU-1bMC33
The construction of SHIVKU-1bMC33 was performed in two
steps and is schematically shown in Fig. 1. The first step
involved insertion of a corrected vpu and the first exons
of tat and rev from SHIVPPc (Stephens et al., 1998b) into
the plasmid with consensus sequences from the
SHIVKU-1b env and first 205 nucleotides of nef (p39-
HIVKU-1b17). The second step involved insertion of the
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121MOLECULAR DETERMINANTS FOR CD41 T CELL LOSSremaining consensus sequences of nef (nucleotides
06–789) from SHIVKU-1b. For insertion of tat, rev, and vpu
sequences, pSHIVPPc3 was digested to completion with
restriction endonucleases SphI and KpnI. The fragment
was purified by electrophoresis through a 1% agarose
gel and purified using GeneClean (US Bio 101, Vista, CA)
according to the manufacturer’s protocols. Plasmid
p39SHIVKU-1b17 was also digested to completion with SphI
and KpnI, and the plasmid was purified as described
above. The fragment, containing the sequence changes
in the vpu (now an open vpu), was ligated into the
SphI–KpnI-digested p39SHIVKU-1b17 using T4 DNA ligase.
The ligated DNA was used to transform competent Esch-
erichia coli (strain DH5a) and transformants screened for
the presence of the DNA fragment with the corrected vpu
gene using primer-directed dideoxy sequencing with Se-
quenase enzyme (US Biochemicals, Cleveland, OH) and
35S-dATP. A clone containing the corrected vpu gene in
39SHIVKU-1b17 was isolated and designated as
p39trvSHIVKU-1bMC17.
For insertion of consensus nef/LTR sequences from
HIVKU-1b, 5 3 10
6 CEMx174 cells were inoculated with
SHIVKU-1b virus and the cellular DNA isolated at 48 h
postinoculation. One microgram of this DNA was used in
PCR (Saiki et al., 1985, 1988) with oligonucleotide primers
59-CCACATACCTAGAAGAATAAGACA-39 (sense) and 59-
TTTAAGCAAGCAAGCGTGGAGTCAC-39 (antisense). The
conditions for amplification were 1.4 mM MgSO4, 200 mM
concentration of each of the four deoxynucleotide
triphosphates, 100 pM concentrations of each oligonu-
cleotide primer, and a mixture of Taq and Pyrococcus
species GB-D polymerases (Elongase; GIBCO BRL,
Gaithersburg, MD). The template was denatured at 94°C
for 2 min, and PCR amplification performed with an
automated DNA Thermal Cycler (Perkin–Elmer Cetus,
Foster City, CA) for 35 cycles using the following profile:
denaturation at 94°C for 30 s, annealing at 65°C for 1
min, and primer extension at 68°C for 5 min. Amplifica-
tion was completed by incubation for 10 min at 68°C. The
DNA fragment that was amplified contained an NcoI site
at the 59 end and a PflMI site at the 39 end. The fragments
were separated on an agarose gel, purified on Gene-
Clean, and then cloned into the pGEM-T vector (Pro-
mega, Madison, WI). Recombinants containing the
SHIVKU-1b nef/LTR region were sequenced, and then one
clone designated as pnef/LTRSHIVKU-1b was used to sub-
clone into the p39trvSHIVKU-1b17. The pnef/LTRSHIVKU-1b
vector was digested with NcoI and PflMI, and the nef/LTR
egion was separated on agarose gels and purified us-
ng GeneClean. This fragment was subcloned into the
39vpuSHIVKU-1b17 vector that was also digested with
NcoI and PflMI and ligated with T4 DNA ligase. The
resulting plasmid was designated as p39SHIVKU-1bMC33.
ecause the only new region of the p39SHIVKU-1bMC33 was
he insert containing the nef gene, this region was se-
uenced using primer-directed dideoxy sequencing us-ng Sequenase enzyme and 35S-dATP. Sequences were
ompared with nef from SHIV-4 (SIVmac239 nef with a
corrected codon at position 92) using the PCGENE se-
quence analysis software programs. For generation of
SHIVKU-1bMC33 virus, p59 SHIV-4 and p39SHIVKU-1bMC33 plas-
ids (containing tat, rev, vpu, and nef genes from
SHIVKU-1b) were digested to completion with SphI, ligated
using T4 DNA ligase, and transfected into C8166 cells
using the DEAE-dextran method as previously described
(Millman and Herzberg, 1981). Infectious virus was ti-
trated in C8166 cells as previously described (Joag et al.,
1996).
Construction of DvpuSHIVKU-1bMC33
To assess the role of Vpu in the CD41 T cell loss
caused by SHIVKU-1bMC33, a deletion mutant of vpu was
onstructed that removed the majority of the coding
equence from this gene. This was accomplished by
ubcloning the SphI–KpnI fragment from p39SHIVKU-1bMC33,
containing the tat, rev, and vpu sequences from
SHIVKU-1bMC33 into the SphI and KpnI sites of plasmid
pUC19 in which the SspI site was removed. This plasmid,
designated as ptrvSHIVKU-1bMC33, was digested to comple-
tion with the restriction endonuclease SspI (which has a
predicted single cleavage site within the vpu gene) and
hen briefly treated with Bal31 exonuclease. The Bal31
xonuclease was inactivated, and the DNA preparation
as digested with BbsI and Klenow DNA polymerase to
reate blunt ends. The treated DNA was religated using
4 DNA ligase and used to transform competent E. coli
strain DH5a). Plasmids isolated from transformants
were screened for the presence or absence of an SspI
site. The inserts of plasmids lacking an SspI site were
sequenced using primer-directed dideoxy sequencing by
Sequenase enzyme (US Biochemicals) and 35S-dATP.
One plasmid, designated as ptrDvpu SHIVKU-1bMC33, was
dentical to ptrvSHIVKU-1bMC33 with the exception of the
deletion of 126 nucleotides (amino acid residues 12–53)
from the vpu gene. The ptrDvpu SHIVKU-1bMC33 was then
digested with SphI–KpnI, gel purified as described
above, and subcloned back into p39SHIVKU-1bMC33 to yield
lasmid p39DvpuSHIVKU-1bMC33. For generation of
DvpuSHIVKU-1bMC33 virus, p59SHIV-4 and p39Dvpu-
SHIVKU-1bMC33 were digested to completion with SphI, li-
gated using T4 DNA ligase, and transfected into C8166
cells using the DEAE-dextran method as previously de-
scribed (Millman and Herzberg, 1981). Infectious virus
was titrated in C8166 cells as previously described (Joag
et al., 1996).
Immune precipitation studies
Immune precipitation assays were performed to deter-
mine whether cells infected with DvpuSHIVKU-1bMC33 stably
expressed the truncated Vpu protein or whether it was
degraded soon after synthesis. C8166 cells were inocu-
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122 MCCORMICK-DAVIS ET AL.lated with 1 ml of undiluted SHIVKU-1bMC33 or Dvpu-
HIVKU-1bMC33 (10
4 TCID50), and cultures were incubated at
37°C for 5 days. At this time, cells were centrifuged and
incubated in methionine/cysteine-free Dulbecco’s modi-
fied Eagle’s medium (DMEM) for 2 h. Cells were then
radiolabeled with 1 mCi of 35S-methionine and cysteine
for 2 h, culture supernatants were harvested, cell lysates
were prepared, and viral proteins were immunoprecipi-
tated with 10 ml of rabbit a-Vpu serum and protein
A–Sepharose as previously described (Stephens et al.,
1995, 1997). Immune precipitates were washed three
times in RIPA buffer, and samples were denatured by
boiling in SDS–PAGE sample reducing buffer. Proteins
were separated using SDS–PAGE (12.5% gel) and visu-
alized using standard autoradiographic techniques.
To determine whether viral structural proteins were
released with reduced efficiency in DvpuSHIVKU-1bMC33-
inoculated cultures, C8166 cells were inoculated as
described above with either DvpuSHIVKU-1bMC33 or
HIVKU-1bMC33. At 5 days postinfection, the medium was
emoved, and infected cells were incubated in methio-
ine/cysteine-free DMEM for 2 h. The cells were then
adiolabeled for 30 min with 1 mCi of 35S-Translabel
(methionine and cysteine; ICN Biomedical, Costa Mesa,
CA), and the radiolabel was chased for various periods
of time in DMEM containing 1003 unlabeled methionine.
SHIV proteins were immune precipitated from the cell
culture medium and infected cell lysates using either
plasma pooled from several rhesus monkeys infected
previously with SHIV KU-1. Briefly, the cell culture medium
as clarified (16,000 g) for 2 min. The supernatant was
ransferred and made 13 with respect to cell lysis buffer
(50 mM Tris–HCl, pH 7.5, 50 mM NaCl, 0.5% deoxy-
cholate, 0.2% SDS, 10 mM EDTA), and SHIV proteins
were immune precipitated with 10 ml of the monkey
serum. For immune precipitation of cell-associated SHIV
proteins, cell lysates were prepared as described previ-
ously (Stephens et al., 1995) before incubation with an-
tiserum. Lysates were centrifuged in a microfuge to re-
move nuclei before the addition of antibody. Cell lysates
and culture medium were incubated with antibody for
16 h at 4°C. All immune precipitates were collected on
protein A–Sepharose, the beads washed three times
with RIPA buffer, and the samples were resuspended in
sample reducing buffer. Samples were boiled, and the
SHIV-specific proteins were analyzed by SDS–PAGE.
Proteins were then visualized by standard fluorographic
techniques.
Macaques and inoculation procedures
Two pig-tailed macaques (50 O and 50 Y) were inoc-
ulated intravenously with 1 ml of undiluted supernatant
from C8166-gown stocks of DvpuSHIVKU-1bMC33 containing
4approximately 10 TCID50/ml. The animals were housed
in our AAALAC-approved animal facility. Heparinized
C
bblood was collected weekly for 4 weeks, then at 2-week
intervals for the next month, and thereafter at monthly
intervals.
Processing of blood and tissue samples
Threefold dilutions of plasma and 10-fold dilutions of
PBMCs (106 cells/ml) were inoculated into replicate cul-
ures of C8166 in 24-well plates, and the cocultures were
xamined for the development of cytopathic effects (Joag
t al., 1996). Infectivity titers in plasma were reported as
CID50/ml, and cells producing infectious cytopathic vi-
rus in the blood were reported as the number of infected
cells/106 PBMCs. Concentrations of CD41 and CD81 T
lymphocytes in the PBMCs were evaluated by FACS
analysis as described previously (Joag et al., 1996). Virus
ontent in tissues obtained at autopsy were determined
n two tests: (1) cells from lymphoid tissues (lymph node
nd spleen) were separated physically by sieving and
ssayed for infectivity as for PBMCs, and (2) cell-free
omogenates prepared from the brain and lung (10%
t/vol) in R10 FBS were assayed for cytopathic virus by
noculation into C8166 cultures.
istopathology
For histopathology, the right half of the brains were
ixed by immersion in 10% neutral buffered formalin,
locked in a standard coronal plane into 6-mm blocks,
ryoprotected in 30% sucrose in 0.1 M phosphate
uffer, and frozen-sectioned at 50 mm using a sliding
icrotome. A 1 in 10 series of these sections was
ounted and stained with 1% thionin to visualize cy-
oarchitecture. Thionin is a Nissl stain, one of several
asic stains used to stain RNA. Nissl stains result in
rominent staining of the nucleolus and endoplasmic
eticulum. Because RNA is localized to the perikaryal
egion and proximal dendrites, the Nissl stains show
he size, shape, and arrangement of neurons and are
sed to study changes in normal cytoarchitecture such
s retrograde degeneration; gliosis and perivascular
uffing are readily visible in this material. To visualize
HC-II and GFAP, sections were incubated free-float-
ng in preblock solution (10% normal goat serum in
BS), washed, and incubated in primary antibody over-
ight at room temperature. Sections were washed,
ncubated in biotinylated goat anti-mouse or anti-rab-
it IgG diluted 1:100, washed, incubated according to
he protocol supplied by Vector Laboratories in their
BC Elite kit, and finally washed and reacted with 0.5%
iaminobenzidine with 0.1% H2O2. The primary anti-
odies used were mouse monoclonal anti-MHC-II
LN-3; ICN Biomedical, Cosa Mesa, CA) diluted 1:200
nd mouse monoclonal anti-GFAP (Boehringer-Mann-
eim Biochemicals, Indianapolis, IN) diluted 1:100.
ontrols consisted of incubation of the sections with
uffer in the place of the primary antibody. Blocks
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123MOLECULAR DETERMINANTS FOR CD41 T CELL LOSScontaining frontal, motor, temporal and occipital cor-
tex, corpus callosum, basal ganglia, midbrain, pons,
medulla, cerebellum, cervical, thoracic and lumbar
spinal cord, and eye were embedded in paraffin and
sectioned at 5 mm, and sections were stained with
hematoxylin and eosin for routine neuropathological
analysis.
PCR analysis of tissues for the presence of viral
sequences
SHIV gag. Visceral organs (ileum, lymph node, spleen,
lung, liver, and thymus) were collected and DNA was iso-
lated as described below. The CNS from infected ma-
caques 50 O and 50 Y was taken at necropsy and dissected
into the following regions: frontal cortex, parietal cortex,
occipital cortex, motor cortex, temporal cortex, corpus cal-
losum, basal ganglia, midbrain, pons, medulla, cerebellum,
cervical spinal cord, thoracic spinal cord, and lumbar spinal
cord. The tissues were homogenized in a tight-fitting
Dounce homogenizer in the presence of 50 mM Tris–HCl,
pH 8.2, 10 mM EDTA, and 0.5% SDS. The homogenate was
digested at 37°C for 2 h in the presence of 100 mg/ml
proteinase K followed by extraction twice with an equal
volume of phenol and once with chloroform:isoamyl alco-
hol. The DNA in the aqueous phase was precipitated with
two volumes of ethanol, pelleted, and resuspended in
DNase-free H2O. We used nested PCR to determine
hether SIV gag sequences were present in the DNA
solated from the various tissues (Joag et al., 1994). In the
irst round, the SIV oligonucleotide primers that were used
ere 59-GATGGGCGTGAGAAACTCCGTCTT-39 (sense) and
9-CCTCCTCTGCCGCTAGATGGTGCTGTTG-39 (antisense),
hich are complementary to bases 1052–1075 and 1423–
450 of the SIVmac239 gag gene, respectively (Regier and
esrosiers, 1990). As an internal control, separate PCRs
ere performed in which the fourth exon of b-actin was
amplified with oligonucleotide primers 59-TCATGTTT-
AGACCTTCAACACCCCAG-59 (sense) and 59-CCAA-
GAAGGAAGGCTGGAAGAGTGCC-59 (antisense) comple-
mentary to the published sequence (Nakijima-Iijima et
al.,1985). The PCR amplification was performed using the
following conditions: denaturation at 92°C for 1 min, an-
nealing at 55°C for 1 min, and primer extension at 72°C for
3 min. To increase the sensitivity of the reaction, 1 ml of the
irst PCR product was used as a template for a second
mplification using the same conditions. The nested SIV
rimers used were 59-GTTGAAGCATGTAGTATGGGC-
GC-39 (sense) and 59-CACCACTAGGTGTCTCTGCAC-
ATCTG-39 (antisense), which are complementary to bases
142–1165 and 1356–1382 of SIVmac239, respectively. The
nested b-actin primers used were 59-CCCCAGCCATG-
ACGTTGCTATCC-39 (sense) and 59-GCCTCAGGGCAG-
GGAACCGCTCA-39 (antisense). Samples were amplifiedor an additional 35 cycles as described above. After the
econd round of amplification, a 10 ml aliquot was removed Tand run on a 1.5% agarose gel, and bands were visualized
by staining with ethidium bromide.
SHIV vpu. The vpu was amplified from several tissue
NA samples taken at necropsy to examine the struc-
ure of vpu. For amplification of the vpu, we used
oligonucleotide primers 59-CCTAGACTAGAGCCCTG-
GAAGCATCC-39 (sense) and 59-GTACCTCTGTAT-
CATATGCTTTAGCAT-39 (antisense), which are comple-
entary to nucleotides 5845–5870 and 6393–6420 of
he HIV-1 (HXB2) genome (Ratner et al., 1985), respec-
ively. One microgram of genomic DNA was used in
he PCR (Saiki et al., 1985, 1988) with Taq DNA poly-
merase and the conditions described above. For the
second round of amplification, we used oligonucleo-
tide primers 59-TTAGGCATCTCCTATGGCAGGAA-
GAAG-39 (sense) and 59-CACAAAATAGAGTGGTGGTT-
GCTTCCT-39 (antisense), which are complementary to
nucleotides 5956–5984 and 6386–6413 of the HIV-1
(HXB2) genome (Ratner et al., 1985), respectively. The
conditions for amplification were identical to those
described above. For sequence analysis, the PCR
products from three separate PCRs were separated by
electrophoresis in a 1% agarose gel, isolated, and
molecularly cloned into the pGEM-T Easy vector ac-
cording to the manufacturer’s instructions. Cycle se-
quencing reactions using the BigDye Terminator Cycle
Sequencing Ready Reaction Kit with AmpliTaq DNA
polymerase, FS (PE Applied Biosystems, Foster City,
CA) and sequence detection was conducted with an
Applied Biosystems 377 Prism XL automated DNA
sequencer and visualized using the ABI Editview pro-
gram. Sequences were compared to the intact and
truncated vpu sequences from SHIVKU-1bMC33 and
DvpuSHIVKU-1bMC33, respectively, using the Omiga 1.1.3
sequence analysis software program.
Detection of SHIV LTR circles. Examination of 2-LTR
circular DNA provides a view of a spreading infection
based on a viral DNA form that is structurally distinct and
known to have a short half-life in infected cells (Pauza et
al., 1994; Zazzi et al., 1997; Teo et al., 1997; Panther et al.,
1998). We analyzed the DNA isolated from ileum, liver,
lymph node, lung, and spleen and the 14 regions of the
CNS for the presence of 2-LTR circular forms of DNA.
The oligonucleotides used in the first round were 59-
ATTTCGCTCTGTATTCAGTCGCTCTGC-39 (U5 region) and
59-CCTCCTGTGCCTCATCTGATACATTTAC-39 (U3 region),
which correspond to bases 10335–10361 and 180–153 of
the SHIV genome, respectively. The PCR amplification
was performed using the following conditions: denatur-
ation at 92°C for 1 min, annealing at 55°C for 1 min, and
primer extension at 72°C for 3 min. One microliter of the
first PCR product was used as a template for a second
amplification using the same conditions. The oligonucle-
otide primers used for the second round were 59-AGGT-
TCTCTCCAGCACTAGCAGGTAGAGC-39 (U5 region) 59-
TGGGTATCTAATTCCTGGTCCTGAG-39 (U3 region; op-
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124 MCCORMICK-DAVIS ET AL.posite strand; 456), which correspond to bases 10389–
10417 and 120–95 of the SHIV genome, respectively.
Samples were amplified for an additional 35 cycles as
described above. After the second round of amplification,
a 10 ml aliquot was removed and run on a 1.5% agarose
el, and the bands were visualized by staining with
thidium bromide. The predicted product of the 2-LTR
CR product is 361 bp.
nalysis of virus loads in macaques
PCR-ICA. The virus loads in the CNS and lymphoid
issues were determined using a quantitative PCR assay
odified from a PCR-infected cell assay previously de-
cribed (Joag et al., 1994; Stephens et al., 1998a). In this
ssay, 1 mg of total cellular DNA isolated from tissues
as subjected to a series of 10-fold dilutions such that
amples contained from 100 ng to 10 fg (less than one
opy of chromosomal DNA). These samples were used
n nested PCR reactions that amplified either the b-actin
gene of the cell (a single copy gene) or the gag gene
from SIVmac239. Amplification of either gene using the
rimers previously described was shown to detect one
opy of each gene (Joag et al., 1994). Thus amplification
f the b-actin gene determined the number of genome
quivalents in each sample, whereas amplification with
he gag primers determined the number of viral copies
er number of genome equivalents. The values were
xpressed as the number of viral copies per 106 genome
equivalents.
p27 assays. Brain tissues were sonicated to generate
cell-free homogenates and analyzed for the levels of
SIVmac p27 core antigen in homogenates (samples were
adjusted to equivalent protein concentrations) using an-
tigen capture assays (Coulter Corp., Hialeah, FL).
Analysis of CNS tissues for CMV and SV-40. We have
previously reported on the PCR assays to detect SV-40 and
rhesus CMV from the brains of diseased macaques
(Raghavan et al., 1997). For the detection of CMV, the oli-
gonucleotides used in the first round were 59- AGATTCTAT-
GGCTATATATGACGTAATGG-39 (sense) and 59-GCAGA-
AAAATAAGGTGTTGTATGCC-39 (antisense) based on the
equence of the rhesus CMV immediate-early gene (Rh-
MV-IE) (Barry et al., 1996). One microliter of the above PCR
roduct was used in nested PCR under the same reaction
onditions using the primers 59-ATGCATGCTATATATGG-
AGGAGG-39 (sense) and 59-GAATAGCGTCACCACTTG-
CAAGGG-39 (antisense), which yielded a 248-bp product.
or the detection of SV-40, the oligonucleotides used in
he first round were 59-ATGGGTGCTGCTTTAACACTGTT-
GG-39 (sense) and 59-AGCCATTCCTGGTTGTTGATATA-
A-39 (antisense) based on the sequence of the SV-40 VP1
ene (Raghavan et al., 1997). One microliter of the above
CR product was used in nested PCR under the sameeaction conditions with the primers 59-CCTAATTGCTACT-
TGTCTGAAGCTGC-39 (sense) and 59-GTAGAAACTTTGT-ATCCCAGTCACTA-39 (antisense), which yielded a 250-bp
roduct.
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